Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304 · see citing works

Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D., Benjamin, D. K., Calandra, T. F., Edwards, J. E., Filler, S. G., Fisher, J. F., Kullberg, B.-J., Zeichner, L. O., et al. (2009) · Clinical Infectious Diseases · doi:10.1086/596757 · Cited by 3,191 · see citing works

Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

Walsh, T. J., Anaissie, E. J., Denning, D. W., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Segal, B. H., Steinbach, W. J., Stevens, D. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/525258 · Cited by 2,685 · see citing works

Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia

Cornely, O. A., Maertens, J. A., Winston, D. J., Perfect, J. R., Ullmann, A. J., Walsh, T. J., HELFGOTT, D. C., Hołowiecki, J., Stockelberg, D., Goh, Y. T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,802 · see citing works

ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients

Cornely, O. A., Bassetti, M., Calandra, T., Garbino, J., Kullberg, B. J., Lortholary, O., Meersseman, W., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12039 · Cited by 1,217 · see citing works

Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: A multi-institutional study.

Garey, K. W., Rege, M., Pai, M. P., Mingo, D. E., Suda, K. J., Turpin, R. S., & Bearden, D. T. (2006) · Clinical Infectious Diseases · doi:10.1086/504810 · Cited by 1,171 · see citing works

Anidulafungin versus Fluconazole for Invasive Candidiasis

Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · see citing works

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

Pascual, A., Calandra, T., Bolay, S., Buclin, T., Bille, J., & Marchetti, O. (2008) · Clinical Infectious Diseases · doi:10.1086/524669 · Cited by 887 · see citing works

Impact of Treatment Strategy on Outcomes in Patients with Candidemia and Other Forms of Invasive Candidiasis: A Patient-Level Quantitative Review of Randomized Trials

Andes, D. R., Safdar, N., Baddley, J. W., Playford, G., Reboli, A. C., Rex, J. H., Sobel, J. D., Pappas, P. G., Kullberg, B. J., & for the Mycoses Study Group (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis021 · Cited by 793 · see citing works

Frequency and Evolution of Azole Resistance in <i>Aspergillus fumigatus</i> Associated with Treatment Failure1

Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750 · see citing works

Treatment of Invasive Aspergillosis with Posaconazole in Patients Who Are Refractory to or Intolerant of Conventional Therapy: An Externally Controlled Trial

Walsh, T. J., RAAD, I. I., Patterson, T. F., Chandrasekar, P. H., Donowitz, G. R., Graybill, R. J., Greene, R. E., Hachem, R. Y., Hadley, S., Herbrecht, R., et al. (2006) · Clinical Infectious Diseases · doi:10.1086/508774 · Cited by 749 · see citing works

Emergence of Azole Resistance in Aspergillus fumigatus and Spread of a Single Resistance Mechanism

Snelders, E., van der Lee, H. A. L., Kuijpers, J., Rijs, A. J. M. M., Varga, J., Samson, R. A., Mellado, E., Donders, A. R. T., Melchers, W. J. G., & Verweij, P. E. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050219 · Cited by 726 · see citing works

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

Kuse, E.-R., Chetchotisakd, P., da Cunha, C. A., Ruhnke, M., Barrios, C., Raghunadharao, D., Sekhon, J. S., Freire, A., Ramasubramanian, V., Demeyer, I., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60605-9 · Cited by 692 · see citing works

Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

Pappas, P. G., Rotstein, C. M. F., Betts, R. F., Nucci, M., Talwar, D., De Waele, J. J., Vazquez, J. A., Dupont, B. F., Horn, D. L., Ostrosky-Zeichner, L., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/520980 · Cited by 638 · see citing works

Azole resistance in Aspergillus fumigatus: a side-effect of environmental fungicide use?

Verweij, P. E., Snelders, E., Kema, G. H., Mellado, E., & Melchers, W. J. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70265-8 · Cited by 604 · see citing works

Chronic Cavitary and Fibrosing Pulmonary and Pleural Aspergillosis: Case Series, Proposed Nomenclature Change, and Review

Denning, D. W., Riniotis, K., Dobrashian, R., & Sambatakou, H. (2003) · Clinical Infectious Diseases · doi:10.1086/376526 · Cited by 551 · see citing works

Resistance to echinocandin-class antifungal drugs.

Perlin, D. S. (2007) · Drug Resistance Updates · doi:10.1016/j.drup.2007.04.002 · Cited by 512 · see citing works

Itraconazole resistance in Aspergillus fumigatus

Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J., Stevens, D. A., Warnock, D. W., & Kelly, S. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1364 · Cited by 507 · see citing works

A New <i>Aspergillus fumigatus</i> Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of <i>cyp51A</i> Alterations

Mellado, E., Garcia-Effron, G., Alcázar-Fuoli, L., Melchers, W. J. G., Verweij, P. E., Cuenca-Estrella, M., & Rodríguez-Tudela, J. L. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01092-06 · Cited by 490 · see citing works

EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03880.x · Cited by 451 · see citing works

NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P. G., Kauffman, C. A., Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Sugar, A. M., Catanzaro, A., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90023-x · Cited by 448 · see citing works

Possible Environmental Origin of Resistance of <i>Aspergillus fumigatus</i> to Medical Triazoles

Snelders, E., Huis in 't Veld, R. A. G., Rijs, A. J. M. M., Kema, G. H. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.00231-09 · Cited by 423 · see citing works

European harmonization of MIC breakpoints for antimicrobial susceptibility testing of bacteria

Kahlmeter, G. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg312 · Cited by 404 · see citing works

Statistical characterisation of bacterial wild-type MIC value distributions and the determination of epidemiological cut-off values

Turnidge, J. D., Kahlmeter, G., & Kronvall, G. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01377.x · Cited by 399 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures.

Cuenca-Estrella, M., Verweij, P. E., Arendrup, M. C., Arikan-Akdagli, S., Bille, J., Donnelly, J. P., Jensen, H. E., Lass-Flörl, C., Richardson, M. D., Akova, M., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12038 · Cited by 386 · see citing works

Frequency of decreased susceptibility and resistance to echinocandins among fluconazole-resistant bloodstream isolates of Candida glabrata

Pfaller, M. A., Castanheira, M., Lockhart, S. R., Ahlquist, A. M., Messer, S. A., & Jones, R. N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.06112-11 · Cited by 377 · see citing works

Epidemiology of invasive candidiasis

Arendrup, M. C. (2010) · Current Opinion in Critical Care · doi:10.1097/mcc.0b013e32833e84d2 · Cited by 376 · see citing works

EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia–forming moulds

* (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02086.x · Cited by 371 · see citing works

Treatment of invasive aspergillosis with itraconazole

Denning, D. W., TUCKER, R. M., Hansen, L., & Stevens, D. A. (1989) · The American Journal of Medicine · doi:10.1016/0002-9343(89)90475-0 · Cited by 364 · see citing works

Recent Exposure to Caspofungin or Fluconazole Influences the Epidemiology of Candidemia: a Prospective Multicenter Study Involving 2,441 Patients

Lortholary, O., Desnos-Ollivier, M., Sitbon, K., Fontanet, A., Bretagne, S., & Dromer, F. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01128-10 · Cited by 362 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.

Hope, W. W., Castagnola, E., Groll, A. H., Roilides, E., Akova, M., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12040 · Cited by 360 · see citing works

Pharmacokinetics and Absorption of Posaconazole Oral Suspension under Various Gastric Conditions in Healthy Volunteers

Krishna, G., Moton, A., Ma, L., Medlock, M. M., & McLeod, J. F. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01034-08 · Cited by 348 · see citing works

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342 · see citing works

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

Pfaller, M. A., Diekema, D. J., Andes, D. R., Arendrup, M. C., Brown, S. D., Lockhart, S. R., Motyl, M. R., & Perlin, D. S. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2011.01.004 · Cited by 335 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)

Ullmann, A. J., Akova, M., Herbrecht, R., Viscoli, C., Arendrup, M. C., Arikan-Akdagli, S., Bassetti, M., Bille, J., Calandra, T., Castagnola, E., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12041 · Cited by 334 · see citing works

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Bueid, A. S., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 333 · see citing works

A Naturally Occurring Proline-to-Alanine Amino Acid Change in Fks1p in <i>Candida parapsilosis</i> , <i>Candida orthopsilosis</i> , and <i>Candida metapsilosis</i> Accounts for Reduced Echinocandin Susceptibility

Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323 · see citing works

Effect of <i>Candida glabrata FKS1</i> and <i>FKS2</i> Mutations on Echinocandin Sensitivity and Kinetics of 1,3-β- <scp>d</scp> -Glucan Synthase: Implication for the Existing Susceptibility Breakpoint

Garcia-Effron, G., Lee, S., Park, S., Cleary, J. D., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00443-09 · Cited by 323 · see citing works

The cdr1B efflux transporter is associated with non-cyp51a-mediated itraconazole resistance in Aspergillus fumigatus

Fraczek, M. G., Bromley, M., Buied, A., Moore, C. B., Rajendran, R., Rautemaa‐Richardson, R., Ramage, G., Denning, D. W., & Bowyer, P. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt075 · Cited by 313 · see citing works

Pharmacology of Itraconazole

De Beule, K., & Van Gestel, J. (2001) · Drugs · doi:10.2165/00003495-200161001-00003 · Cited by 283 · see citing works

A Point Mutation in the 14α-Sterol Demethylase Gene <i>cyp51A</i> Contributes to Itraconazole Resistance in <i>Aspergillus fumigatus</i>

Diaz-Guerra, T. M., Mellado, E., Cuenca-Estrella, M., & Rodriguez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.1120-1124.2003 · Cited by 281 · see citing works

Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001‐2007): Stable incidence but changing epidemiology of a still frequently lethal infection

Sipsas, N. V., Lewis, R. E., Tarrand, J., Hachem, R., Rolston, K. V., Raad, I. I., & Kontoyiannis, D. P. (2009) · Cancer · doi:10.1002/cncr.24507 · Cited by 269 · see citing works

Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints

Verweij, P. E., Howard, S. J., Melchers, W. J. G., & Denning, D. W. (2009) · Drug Resistance Updates · doi:10.1016/j.drup.2009.09.002 · Cited by 258 · see citing works

Correlating Echinocandin MIC and Kinetic Inhibition of <i>fks1</i> Mutant Glucan Synthases for <i>Candida albicans</i> : Implications for Interpretive Breakpoints

Garcia-Effron, G., Park, S., & Perlin, D. S. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01162-08 · Cited by 256 · see citing works

Exposure–Response of Posaconazole Used for Prophylaxis Against Invasive Fungal Infections: Evaluating the Need to Adjust Doses Based on Drug Concentrations in Plasma

Jang, S., Colangelo, P. M., & Gobburu, J. V. S. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.64 · Cited by 239 · see citing works

Environmental Study of Azole-Resistant Aspergillus fumigatus and Other Aspergilli in Austria, Denmark, and Spain

Mortensen, K. L., Mellado, E., Lass‐Flörl, C., Rodrı́guez-Tudela, J. L., Johansen, H. K., & Arendrup, M. C. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00692-10 · Cited by 238 · see citing works

Azole Resistance in Aspergillus fumigatus Isolates from the ARTEMIS Global Surveillance Study Is Primarily Due to the TR/L98H Mutation in the cyp51A Gene

Lockhart, S. R., Frade, J. P., Etienne, K. A., Pfaller, M. A., Diekema, D. J., & Balajee, S. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00185-11 · Cited by 232 · see citing works

Rapid Induction of Multiple Resistance Mechanisms in Aspergillus fumigatus during Azole Therapy: a Case Study and Review of the Literature

Camps, S. M. T., van der Linden, J. W. M., Li, Y., Kuijper, E. J., van Dissel, J. T., Verweij, P. E., & Melchers, W. J. G. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05088-11 · Cited by 229 · see citing works

Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics

Willems, L., van der Geest, R., & Beule, K. D. (2001) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2001.00338.x · Cited by 226 · see citing works

<i>In Vivo</i> Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against <i>Candida</i> Species

Andes, D., Diekema, D. J., Pfaller, M. A., Bohrmuller, J., Marchillo, K., & Lepak, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01584-09 · Cited by 226 · see citing works

Observational Study of the Clinical Efficacy of Voriconazole and Its Relationship to Plasma Concentrations in Patients

Troke, P. F., Hockey, H. P., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01083-10 · Cited by 217 · see citing works

Interlaboratory variability of caspofungin MICs for Candida spp. using CLSI and EUCAST methods: Should the clinical laboratory be testing this agent?

Espinel-Ingroff, A., Arendrup, M. C., Pfaller, M. A., Bonfietti, L. X., Bustamante, B., Canton, E., Chryssanthou, E., Cuenca-Estrella, M., Dannaoui, E., Fothergill, A., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01519-13 · Cited by 216 · see citing works

Discovery of a hapE Mutation That Causes Azole Resistance in Aspergillus fumigatus through Whole Genome Sequencing and Sexual Crossing

Camps, S. M. T., Dutilh, B. E., Arendrup, M. C., Rijs, A. J. M. M., Snelders, E., Huynen, M. A., Verweij, P. E., & Melchers, W. J. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050034 · Cited by 208 · see citing works

Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme

Arendrup, M. C., Dzajic, E., Jensen, R. H., Johansen, H. K., Kjaldgaard, P., Knudsen, J. D., Kristensen, L., Leitz, C., Lemming, L. E., Nielsen, L., et al. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12212 · Cited by 206 · see citing works

Acquired antifungal drug resistance inAspergillus fumigatus:epidemiology and detection

Howard, S. J., & Arendrup, M. C. (2010) · Medical Mycology · doi:10.3109/13693786.2010.508469 · Cited by 199 · see citing works

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196 · see citing works

Antifungal Prophylaxis with Itraconazole in Prolonged Neutropenia: Correlation with Plasma Levels

Boogaerts, M. A., Verhoef, G. E. G., Zachée, P., Demuynck, H., Verbist, L., & Beule, K. D. (1989) · Mycoses · doi:10.1111/j.1439-0507.1989.tb02299.x · Cited by 189 · see citing works

Isolation of multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR/L98H mutations in the cyp51A gene in India

Chowdhary, A., Kathuria, S., Randhawa, H. S., Gaur, S. N. S., Klaassen, C. H. W., & Meis, J. F. G. M. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr443 · Cited by 187 · see citing works

Diagnostic Issues, Clinical Characteristics, and Outcomes for Patients with Fungemia

Arendrup, M. C., Sulim, S., Holm, A., Nielsen, L. B., Nielsen, S. D., Knudsen, J. D., Drenck, N. E., Christensen, J. J., & Johansen, H. K. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00179-11 · Cited by 177 · see citing works

Development of Azole Resistance in Aspergillus fumigatus during Azole Therapy Associated with Change in Virulence

Arendrup, M. C., Mavridou, E., Mortensen, K. L., Snelders, E., Møller, J. K., Khan, H., Melchers, W. J. G., & Verweij, P. E. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010080 · Cited by 175 · see citing works

Optimisation of Itraconazole Therapy Using Target Drug Concentrations

Poirier, M., & CHEYMOL, G. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199835060-00004 · Cited by 172 · see citing works

Comparison of the Vitek 2 Antifungal Susceptibility System with the Clinical and Laboratory Standards Institute (CLSI) and European Committee on Antimicrobial Susceptibility Testing (EUCAST) Broth Microdilution Reference Methods and with the Sensititre YeastOne and Etest Techniques for In Vitro Detection of Antifungal Resistance in Yeast Isolates

Cuenca‐Estrella, M., Gómez‐López, A., Alastruey‐Izquierdo, A., Bernal‐Martínez, L., Cuesta, I., Buitrago, M. J., & Rodrı́guez-Tudela, J. L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02316-09 · Cited by 172 · see citing works

The Presence of an <i>FKS</i> Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171 · see citing works

In Vivo Pharmacodynamics of Antifungal Drugs in Treatment of Candidiasis

Andes, D. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1179-1186.2003 · Cited by 170 · see citing works

In Vivo Pathogenicity of Eight Medically Relevant Candida Species in an Animal Model

Arendrup, M. C., Horn, T. D., & Møller, J. K. (2002) · Infection · doi:10.1007/s15010-002-2131-0 · Cited by 167 · see citing works

Association of fluconazole pharmacodynamics with mortality in patients with candidemia

Baddley, J. W., Patel, M., Bhavnani, S. M., Moser, S. A., & Andes, D. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-08 · Cited by 162 · see citing works

Echinocandin Susceptibility Testing of<i>Candida</i>Species: Comparison of EUCAST EDef 7.1, CLSI M27-A3, Etest, Disk Diffusion, and Agar Dilution Methods with RPMI and IsoSensitest Media

Arendrup, M. C., Garcia-Effron, G., Lass-Flörl, C., Lopez, A. G., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., & Perlin, D. S. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01256-09 · Cited by 158 · see citing works

Intravenous Itraconazole Followed by Oral Itraconazole in the Treatment of Invasive Pulmonary Aspergillosis in Patients with Hematologic Malignancies, Chronic Granulomatous Disease, or AIDS

Caillot, D., Bassaris, H. P., McGeer, A., Arthur, C., Prentice, H. G., Seifert, W., & Beule, K. D. (2001) · Clinical Infectious Diseases · doi:10.1086/323020 · Cited by 158 · see citing works

Untitled work

(2013) · PubMed · Cited by 150 · see citing works

Breakthrough invasive fungal infections in neutropenic patients after prophylaxis with itraconazole

Glasmacher, A. G., Hahn, C., Leutner, C., Molitor, E., Wardelmann, E., Losem, C. J., Sauerbruch, T., Marklein, G., & Schmidt‐Wolf, I. G. H. (1999) · Mycoses · doi:10.1046/j.1439-0507.1999.00505.x · Cited by 147 · see citing works

Single-Dose Phase I Study To Evaluate the Pharmacokinetics of Posaconazole in New Tablet and Capsule Formulations Relative to Oral Suspension

Krishna, G., Ma, L., Martinho, M., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00222-12 · Cited by 145 · see citing works

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.

Forrest, G. N., Weekes, E., & Johnson, J. K. (2008) · Journal of Infection · doi:10.1016/j.jinf.2007.10.014 · Cited by 144 · see citing works

In vivo pharmacodynamic characterization of anidulafungin in a neutropenic murine candidiasis model

Andes, D., Diekema, D. J., Pfaller, M. A., Prince, R. A., Marchillo, K., Ashbeck, J., & Hou, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01061-07 · Cited by 140 · see citing works

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia

Rodríguez-Tudela, J. L., Almirante, B., Rodríguez-Pardo, D., Laguna, F., Donnelly, J. P., Mouton, J. W., Pahissa, A., & Cuenca-Estrella, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-07 · Cited by 137 · see citing works

In Vivo Pharmacodynamic Target Investigation for Micafungin against <i>Candida albicans</i> and <i>C. glabrata</i> in a Neutropenic Murine Candidiasis Model

Andes, D. R., Diekema, D. J., Pfaller, M. A., Marchillo, K., & Bohrmueller, J. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00478-08 · Cited by 134 · see citing works

Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections

Lestner, J. M., & Hope, W. W. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.794785 · Cited by 131 · see citing works

<i>Candida</i> spp. with Acquired Echinocandin Resistance, France, 2004–20101

Dannaoui, E., Desnos-Ollivier, M., Garcia-Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., Lortholary, O., & the French Mycoses Study Group (2012) · Emerging infectious diseases · doi:10.3201/eid1801.110556 · Cited by 130 · see citing works

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest Methods with the CLSI Broth Microdilution Method for Echinocandin Susceptibility Testing of Candida Species

Pfaller, M. A., Castanheira, M., Diekema, D. J., Messer, S. A., Moet, G. J., & Jones, R. N. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02445-09 · Cited by 127 · see citing works

Breakthrough Aspergillus fumigatus and Candida albicans Double Infection during Caspofungin Treatment: Laboratory Characteristics and Implication for Susceptibility Testing

Arendrup, M. C., García‐Effrón, G., Buzina, W., Mortensen, K. L., Reiter, N., Lundin, C., Jensen, H. E., Lass‐Flörl, C., Perlin, D. S., & Bruun, B. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01292-08 · Cited by 124 · see citing works

EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole

Arendrup, M. C., Cuenca‐Estrella, M., Lass‐Flörl, C., & Hope, W. W. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03890.x · Cited by 122 · see citing works

Low prevalence of resistance to azoles in Aspergillus fumigatus in a French cohort of patients treated for haematological malignancies

Alanio, A., Sitterlé, E., Liance, M., Farrugia, C., Foulet, F., Botterel, F., Hicheri, Y., Cordonnier, C., Costa, J., & Bretagne, S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq450 · Cited by 122 · see citing works

Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia

Andes, D. R., Ambrose, P. G., Hammel, J., Wart, S. A. V., Iyer, V., Reynolds, D. K., Buell, D. N., Kovanda, L. L., & Bhavnani, S. M. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01430-10 · Cited by 119 · see citing works

Differential <i>In Vivo</i> Activities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and without <i>FKS</i> Resistance Mutations

Arendrup, M. C., Perlin, D. S., Jensen, R. H., Howard, S. J., Goodwin, J., & Hope, W. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.06369-11 · Cited by 117 · see citing works

Population Pharmacokinetics of Voriconazole in Adults

Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00702-11 · Cited by 116 · see citing works

The structure–function relationship of the Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis: The mechanism of L98H azole resistance

Snelders, E., Karawajczyk, A., Verhoeven, R. J. A., Venselaar, H., Schaftenaar, G., Verweij, P. E., & Melchers, W. J. G. (2011) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2011.08.002 · Cited by 113 · see citing works

Efficacy of Posaconazole against Three Clinical Aspergillus fumigatus Isolates with Mutations in the cyp51A Gene

Mavridou, E., Brüggemann, R. J. M., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00931-09 · Cited by 112 · see citing works

ESCMID guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS

Lortholary, O., Πετρίκκος, Γ., Akova, M., Arendrup, M. C., Arıkan-Akdağlı, S., Bassetti, M., Billé, J., Calandra, T., Castagnola, E., Cornely, O. A., et al. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12042 · Cited by 108 · see citing works

Pharmacokinetics and Pharmacodynamics of Posaconazole for Invasive Pulmonary Aspergillosis: Clinical Implications for Antifungal Therapy

Howard, S. J., Lestner, J. M., Sharp, J., Gregson, L., Goodwin, J., Slater, J., Majithiya, J. B., Warn, P. A., & Hope, W. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir023 · Cited by 106 · see citing works

Caspofungin MICs correlate with treatment outcomes among patients with Candida glabrata invasive candidiasis and prior echinocandin exposure.

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105 · see citing works

Novel FKS Mutations Associated with Echinocandin Resistance in Candida Species

García‐Effrón, G., Chua, D. J., Tomada, J. R. T., DiPersio, J. R., Perlin, D. S., Ghannoum, M. A., & Bonilla, H. F. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00998-09 · Cited by 104 · see citing works

Azole Resistance in Aspergillus : A Growing Public Health Menace

Denning, D. W., & Perlin, D. S. (2011) · Future Microbiology · doi:10.2217/fmb.11.118 · Cited by 100 · see citing works

Azole Resistance In Aspergillus Fumigatus : A New Challenge In The Management Of Invasive Aspergillosis?

Snelders, E., Melchers, W. J. G., & Verweij, P. E. (2011) · Future Microbiology · doi:10.2217/fmb.11.4 · Cited by 96 · see citing works

In Vitro Activities of Isavuconazole and Comparator Antifungal Agents Tested against a Global Collection of Opportunistic Yeasts and Molds

Pfaller, M. A., Messer, S. A., Rhomberg, P. R., Jones, R. N., & Castanheira, M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00863-13 · Cited by 85 · see citing works

Azole‐Resistant Central Nervous System Aspergillosis

van der Linden, J. W. M., Jansen, R. R., Bresters, D., Visser, C. E., Geerlings, S. E., Kuijper, E. J., Melchers, W. J. G., & Verweij, P. E. (2009) · Clinical Infectious Diseases · doi:10.1086/597465 · Cited by 84 · see citing works

In Vitro Activity of Isavuconazole against Aspergillus Species and Zygomycetes According to the Methodology of the European Committee on Antimicrobial Susceptibility Testing

Perkhofer, S., Lechner, V., & Lass‐Flörl, C. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01530-08 · Cited by 80 · see citing works

Concentration of Antifungal Agents within Host Cell Membranes: a New Paradigm Governing the Efficacy of Prophylaxis

Campoli, P., Abdallah, Q. A., Robitaille, R., Solis, N. V., Fielhaber, J. A., Kristof, A. S., Laverdière, M., Filler, S. G., & Sheppard, D. C. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00637-11 · Cited by 77 · see citing works

Comparison of the Sensititre YeastOne colorimetric antifungal panel with CLSI microdilution for antifungal susceptibility testing of the echinocandins against Candida spp., using new clinical breakpoints and epidemiological cutoff values

Pfaller, M. A., Chaturvedi, V. P., Diekema, D. J., Ghannoum, M. A., Holliday, N. M., Killian, S. B., Knapp, C. C., Messer, S. A., Miskou, A., & Ramani, R. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.05.008 · Cited by 75 · see citing works

Candida palmioleophila: characterization of a previously overlooked pathogen and its unique susceptibility profile in comparison with five related species.

Jensen, R. H., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02071-10 · Cited by 68 · see citing works

Azole-Resistant Invasive Aspergillosis: Relationship to Agriculture

Stensvold, C. R., Jørgensen, L. N., & Arendrup, M. C. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-012-0097-7 · Cited by 67 · see citing works

Caspofungin Etest susceptibility testing of Candida species: risk of misclassification of susceptible isolates of C. glabrata and C. krusei when adopting the revised CLSI caspofungin breakpoints.

Arendrup, M. C., Pfaller, M. A., & the Danish Fungaemia Study Group (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00355-12 · Cited by 67 · see citing works

Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques

Cuenca‐Estrella, M., Gómez‐López, A., Mellado, E., & Rodriguez-Tudela, J. L. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2005.01166.x · Cited by 66 · see citing works

Determination of Isavuconazole Susceptibility of Aspergillus and Candida Species by the EUCAST Method

Howard, S. J., Lass‐Flörl, C., Cuenca‐Estrella, M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01111-13 · Cited by 66 · see citing works

Breakpoints for Susceptibility Testing Should Not Divide Wild-Type Distributions of Important Target Species

Arendrup, M. C., Kahlmeter, G., Rodrı́guez-Tudela, J. L., & Donnelly, J. P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01624-08 · Cited by 62 · see citing works

EUCAST Technical Note on voriconazole

* (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.02087.x · Cited by 59 · see citing works

Echinocandin Susceptibility Testing of <i>Candida</i> spp. Using EUCAST EDef 7.1 and CLSI M27-A3 Standard Procedures: Analysis of the Influence of Bovine Serum Albumin Supplementation, Storage Time, and Drug Lots

Arendrup, M. C., Rodriguez-Tudela, J.-L., Park, S., Garcia-Effron, G., Delmas, G., Cuenca-Estrella, M., Gomez-Lopez, A., & Perlin, D. S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01364-10 · Cited by 57 · see citing works

Rapid emergence of echinocandin resistance during Candida kefyr fungemia treatment with caspofungin

Fekkar, A., Meyer, I., Brossas, J. Y., Dannaoui, E., Palous, M., Uzunov, M., Nguyen, S., Leblond, V., Mazier, D., & Datry, A. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02037-12 · Cited by 56 · see citing works

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying <i>FKS</i> Mutant Candida glabrata Strains and Echinocandin Resistance

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56 · see citing works

Disseminated Candidiasis Caused by Candida albicans with Amino Acid Substitutions in Fks1 at Position Ser645 Cannot Be Successfully Treated with Micafungin

Slater, J. L., Howard, S. J., Sharp, J., Goodwin, J., Gregson, L., Alastruey‐Izquierdo, A., Arendrup, M. C., Warn, P. A., Perlin, D. S., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01686-10 · Cited by 52 · see citing works

Therapeutic drug monitoring of posaconazole in hematology adults under posaconazole prophylaxis: influence of food intake

Eiden, C., Meniane, J.-C., Peyrière, H., Eymard‐Duvernay, S., Falher, G. L., Céballos, P., Fegueux, N., Cociglio, M., Reynes, J., & Hillaire‐Buys, D. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1288-9 · Cited by 51 · see citing works

Pharmacokinetics of Posaconazole Within Epithelial Cells and Fungi: Insights Into Potential Mechanisms of Action During Treatment and Prophylaxis

Campoli, P., Perlin, D. S., Kristof, A. S., White, T. C., Filler, S. G., & Sheppard, D. C. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit358 · Cited by 50 · see citing works

EUCAST technical note on Amphotericin B

Lass-Flörl, C., Arendrup, M. C., Rodriguez-Tudela, J.-L., Cuenca-Estrella, M., Donnelly, P., & Hope, W. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03644.x · Cited by 49 · see citing works

Pharmacodynamics of echinocandins against Candida glabrata: requirement for dosage escalation to achieve maximal antifungal activity in neutropenic hosts

Howard, S. J., Livermore, J., Sharp, A., Goodwin, J., Gregson, L., Alastruey-Izquierdo, A., Perlin, D. S., Warn, P. A., & Hope, W. W. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00621-11 · Cited by 48 · see citing works

Stepwise development of a homozygous S80P substitution in Fks1p, conferring echinocandin resistance in Candida tropicalis.

Jensen, R. H., Johansen, H. K., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01193-12 · Cited by 47 · see citing works

<scp>EUCAST</scp> Technical Note on <i>Candida</i> and micafungin, anidulafungin and fluconazole

Cavling Arendrup, M., Cuenca‐Estrella, M., Lass‐Flörl, C., Hope, W. W., & The European Committee on Antimicrobial Susceptibility Testing – Subcommittee on Antifungal Susceptibility Testing (EUCAST‐AFST) (2014) · Mycoses · doi:10.1111/myc.12170 · Cited by 43 · see citing works

Evaluation of Caspofungin Susceptibility Testing by the New Vitek 2 AST-YS06 Yeast Card Using a Unique Collection of <i>FKS</i> Wild-Type and Hot Spot Mutant Isolates, Including the Five Most Common Candida Species

Astvad, K. M., Perlin, D. S., Johansen, H. K., Jensen, R. H., & Arendrup, M. C. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01382-12 · Cited by 43 · see citing works

Pharmacodynamics of Voriconazole in a Dynamic In Vitro Model of Invasive Pulmonary Aspergillosis: Implications for In Vitro Susceptibility Breakpoints

Jeans, A. R., Howard, S. J., Al-Nakeeb, Z., Goodwin, J., Gregson, L., Majithiya, J. B., Lass‐Flörl, C., Cuenca‐Estrella, M., Arendrup, M. C., Warn, P. A., et al. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis372 · Cited by 42 · see citing works

EUCAST breakpoints for antifungals

Rodrı́guez-Tudela, J. L., Arendrup, M. C., Cuenca‐Estrella, M., Donnelly, J. P., & Lass‐Flörl, C. (2010) · Drug News & Perspectives · doi:10.1358/dnp.2010.23.2.1400855 · Cited by 41 · see citing works

Failure of Posaconazole Therapy in a Renal Transplant Patient with Invasive Aspergillosis Due to Aspergillus fumigatus with Attenuated Susceptibility to Posaconazole

Kuipers, S., Brüggemann, R. J. M., de Sévaux, R. G. L., Heesakkers, J. P. F. A., Melchers, W. J. G., Mouton, J. W., & Verweij, P. E. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01544-10 · Cited by 41 · see citing works

Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations.

Poirier, J., Berlioz, F., Isnard, F., & CHEYMOL, G. (1996) · PubMed · Cited by 40 · see citing works

Population pharmacokinetics of posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome

Abutarif, M. A., Krishna, G., & Statkevich, P. (2009) · Current Medical Research and Opinion · doi:10.1185/03007990903485056 · Cited by 40 · see citing works

Frequency, diagnosis and management of fungal respiratory infections

Hayes, G., & Denning, D. W. (2013) · Current Opinion in Pulmonary Medicine · doi:10.1097/mcp.0b013e32835f1ad1 · Cited by 39 · see citing works

Mixed treatment comparison of prophylaxis against invasive fungal infections in neutropenic patients receiving therapy for haematological malignancies: a systematic review

Pechlivanoglou, P., Le, H. H., Daenen, S. M. G. J., Snowden, J. A., & Postma, M. J. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt329 · Cited by 34 · see citing works

Posaconazole: The Case for Therapeutic Drug Monitoring

Howard, S. J., Felton, T., Gómez‐López, A., & Hope, W. W. (2011) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31823cdeac · Cited by 32 · see citing works

Echinocandin Susceptibility Testing of Candida Isolates Collected during a 1-Year Period in Sweden

Elings, M. A., Botero-Kleiven, S., Hare, R. K., & Arendrup, M. C. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00201-11 · Cited by 30 · see citing works

Candida spp. with Acquired Echinocandin Resistance, France,

Dannaoui, É., Desnos‐Ollivier, M., Garcia‐Hermoso, D., Grenouillet, F., Cassaing, S., Baixench, M.-T., Bretagne, S., Dromer, F., & Lortholary, O. (2012) · Cited by 27 · see citing works

The impact of azole resistance on aspergillosis guidelines

Georgiadou, S. P., & Kontoyiannis, D. P. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06795.x · Cited by 25 · see citing works

A case of kerion celsi caused byMicrosporum gypseumin a boy following dermatoplasty for a scalp wound from a road accident

Zhang, R., Ran, Y., Dai, Y., et al. (2010) · Medical Mycology · doi:10.3109/13693786.2010.503196 · Cited by 24 · see citing works

Azole resistance in Aspergillus: global status in Europe and Asia

Arıkan-Akdağlı, S. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06815.x · Cited by 21 · see citing works

Comparison of Anidulafungin MICs Determined by the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document) and Etest for Candida Species Isolates

Espinel‐Ingroff, A., Cantón, R., Pemán, J., & Martín‐Mazuelos, E. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01324-09 · Cited by 21 · see citing works

Plasma Itraconazole Concentrations in Patients With Neutropenia

Poirier, J., Hardy, S., Isnard, F., et al. (1997) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199710000-00007 · Cited by 21 · see citing works

Association of Fluconazole Pharmacodynamics with Mortality in Patients with Candidemia

Arendrup, M. C., Cuenca‐Estrella, M., Donnelly, J. P., Lass‐Flörl, C., & Rodrı́guez-Tudela, J. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01411-08 · Cited by 16 · see citing works

Pharmacokinetics and pharmacodynamics in the development of antifungal compounds.

Andes, D. R. (2003) · PubMed · Cited by 15 · see citing works

Azole resistance in Aspergillus: an emerging problem?

Vermeulen, E., Cooreman, S., Maertens, J. A., et al. (2013) · PubMed · doi:10.2143/acb.67.5.2062684 · Cited by 8 · see citing works

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw326 · Cited by 2,926 · see citing works

Invasive candidiasis

Pappas, P. G., Lionakis, M. S., Arendrup, M. C., Ostrosky-Zeichner, L., & Kullberg, B. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.26 · Cited by 1,636 · see citing works

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556 · see citing works

The global problem of antifungal resistance: prevalence, mechanisms, and management

Perlin, D. S., Rautemaa-Richardson, R., & Alastruey-Izquierdo, A. (2017) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30316-x · Cited by 1,055 · see citing works

Echinocandin resistance in Candida.

Perlin, D. S. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/civ791 · Cited by 374 · see citing works

Mechanisms of echinocandin antifungal drug resistance

Perlin, D. S. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12831 · Cited by 313 · see citing works

Echinocandin resistance: an emerging clinical problem?

Arendrup, M. C., & Perlin, D. S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000111 · Cited by 299 · see citing works

Echinocandins for the treatment of invasive aspergillosis: from laboratory to bedside

Aruanno, M., Glampedakis, E., & Lamoth, F. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00399-19 · Cited by 136 · see citing works

Antifungal Pharmacokinetics and Pharmacodynamics

Lepak, A. J., & Andes, D. R. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a019653 · Cited by 134 · see citing works

Defining the frontiers between antifungal resistance, tolerance and the concept of persistence

Delarze, E., & Sanglard, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.10.001 · Cited by 118 · see citing works

Molecular basis of antifungal drug resistance in yeasts

Morio, F., Jensen, R. H., Le Pape, P., & Arendrup, M. C. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.05.012 · Cited by 114 · see citing works

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species

Dudakova, A., Spiess, B., Tangwattanachuleeporn, M., Sasse, C., Buchheidt, D., Weig, M., Groß, U., & Bader, O. (2017) · Clinical Microbiology Reviews · doi:10.1128/cmr.00095-16 · Cited by 113 · see citing works

Echinocandin Resistance, Susceptibility Testing and Prophylaxis: Implications for Patient Management

Perlin, D. S. (2014) · Drugs · doi:10.1007/s40265-014-0286-5 · Cited by 99 · see citing works

Stepwise emergence of azole, echinocandin and amphotericin B multidrug resistance<i>in vivo</i>in<i>Candida albicans</i>orchestrated by multiple genetic alterations

Jensen, R. H., Astvad, K. M. T., Silva, L. V., Sanglard, D., Jørgensen, R., Nielsen, K. F., Mathiasen, E. G., Doroudian, G., Perlin, D. S., & Arendrup, M. C. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv140 · Cited by 95 · see citing works

Posttreatment Antifungal Resistance among Colonizing Candida Isolates in Candidemia Patients: Results from a Systematic Multicenter Study

Jensen, R. H., Johansen, H. K., Søes, L. M., Lemming, L. E., Rosenvinge, F. S., Nielsen, L., Olesen, B., Kristensen, L., Dzajic, E., Astvad, K. M. T., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01763-15 · Cited by 77 · see citing works

Fluconazole and Echinocandin resistance of Candida glabrata correlates better with antifungal drug exposure rather than with MSH2 mutator genotype in a French Cohort of patients harboring low rates of resistance.

Dellière, S., Healey, K., Gits-Muselli, M., Carrara, B., Barbaro, A., Guigue, N., Lecefel, C., Touratier, S., Desnos-Ollivier, M., Perlin, D. S., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02038 · Cited by 75 · see citing works

Emerging echinocandin-resistant Candida albicans and glabrata in Switzerland

Coste, A. T., Kritikos, A., Li, J., Khanna, N., Goldenberger, D., Garzoni, C., Zehnder, C., Boggian, K., Neofytos, D., Riat, A., et al. (2020) · Infection · doi:10.1007/s15010-020-01475-8 · Cited by 69 · see citing works

Antifungal resistance to fluconazole and echinocandins is not emerging in yeast isolates causing fungemia in a Spanish tertiary care center.

Marcos-Zambrano, L. J., Escribano, P., Sánchez, C., Muñoz, P., Bouza, E., & Guinea, J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02670-14 · Cited by 49 · see citing works

Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?

Bassetti, M., Vena, A., Bouza, E., Peghin, M., Muñoz, P., Righi, E., Pea, F., Lackner, M., & Lass-Flörl, C. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.02.017 · Cited by 40 · see citing works

Echinocandin Antifungal Drug Resistance in Candida Species: A Cause for Concern?

Sanguinetti, M., Posteraro, P., & Posteraro, B. (2010) · Current Infectious Disease Reports · doi:10.1007/s11908-010-0131-2 · Cited by 16 · see citing works

Critical Assessment of Cell Wall Integrity Factors Contributing to in vivo Echinocandin Tolerance and Resistance in Candida glabrata

Garcia-Rubio, R., Hernandez, R. Y., Clear, A., Healey, K. R., Shor, E., & Perlin, D. S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.702779 · Cited by 35 · see citing works

Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?

Fekkar, A., Dannaoui, É., Meyer, I., Imbert, S., Brossas, J., Uzunov, M., Mellon, G., Nguyen‐Quoc, S., Guiller, E., Caumes, É., et al. (2014) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2096-9 · Cited by 63 · see citing works

Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review

Sun, H., & Singh, N. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.09.020 · Cited by 66 · see citing works

Role of FKS Gene in the Susceptibility of Pathogenic Fungi to Echinocandins

Hori, Y., & Shibuya, K. (2018) · Medical Mycology Journal · doi:10.3314/mmj.18.004 · Cited by 28 · see citing works